Rejish Thomas Selected Research

Esketamine

1/2023

Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rejish Thomas Research Topics

Disease

1	Treatment-Resistant Depressive Disorder 01/2023
1	Cognitive Dysfunction 01/2019
1	Schizophrenia (Dementia Praecox) 01/2019

Drug/Important Bio-Agent (IBA)

1	EsketamineIBA 01/2023
1	Ketamine FDA LinkGeneric 01/2023
1	EnzymesIBA 01/2019
1	Serine (L-Serine)FDA Link 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	serine racemaseIBA 01/2019
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2019